Previous 10 | Next 10 |
REDWOOD CITY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today announced that it will report financial results for the fourth quarter and full year 2023 on Mon...
2024-02-18 06:39:11 ET Summary This article provides a monthly dashboard with aggregate industry metrics in the healthcare sector. Fast facts on IDNA, a thematic and volatile biotech ETF. We conclude with 10 healthcare stocks cheaper than their peers in February. ... ...
2024-02-14 17:06:13 ET More on Illumina Illumina, Inc. (ILMN) Q4 2023 Earnings Call Transcript Illumina: One Of The Most Hated Stocks In Healthcare Is Looking Like A Strong Buy Illumina: Volatility Galore, But Not Much Prospect Of Progress In 2024 Analyst rea...
2024-02-05 16:55:17 ET Gainers: Semper Paratus Acquisition ( LGST ) +13% . Graphite ( GRPH ) +12% . Varonis Systems ( VRNS ) +8% . NXP Semiconductors ( NXPI ) +3% . Spruce Biosciences ( SPRB ) +3% . Losers: Sy...
2024-01-11 05:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
REDWOOD CITY, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairm...
2023-12-25 02:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-11-16 13:24:33 ET More on Revolution Medicines Revolution Medicines: A March Halted By 'Lackluster' ESMO Readout Revolution Medicines, Inc. 2023 Q3 - Results - Earnings Call Presentation Revolution Medicines, Inc. (RVMD) Q3 2023 Earnings Conference Call Transcri...
2023-11-14 16:01:42 ET More on EQRx, Globalstar, etc. Globalstar: The Positives And Negatives Weigh Into A Hold Rating Revolution Medicines: A March Halted By 'Lackluster' ESMO Readout SoftBank Group Corp. (SFTBY) Q2 2023 Earnings Call Transcript Revolu...
2023-11-10 11:26:23 ET Summary Revolution Medicines has presented positive data from their ongoing phase 1 study for their RAS(ON) inhibitors, showing promising response rates in patients with lung and pancreatic cancer. The market did not react positively to the data, leading to ...
News, Short Squeeze, Breakout and More Instantly...
Revolution Medicines Inc. Company Name:
RVMD Stock Symbol:
NASDAQ Market:
Revolution Medicines Inc. Website:
2024-07-14 06:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Original research published in Cancer Discovery reveals a RAS(ON) multi-selective inhibitor exhibited robust anti-tumor activity alone or in combination with a RAS(ON) G12C-selective inhibitor in preclinical models of difficult-to-treat KRAS-mutated non-small cell lung cancer (NSCLC) Re...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) fell 9.3% to $0.2448 on volume of 58,139,351 shares NVIDIA Corporation (NVDA) rose 2.9% to $131.9 on volume of 38,975,630 shares Soligenix Inc. (SNGX) rose 189.2% to $5.784 on volume of 36,915,609...